In addition, for postoperative patients, especially those requiring adjuvant therapy after surgery, TIME could be used to predict the benefit of adjuvant chemotherapy, and based on the detection of TIME, such CD8+ T cells infiltrated in the tumor could screen patients more suitable for adjuvant chemotherapy. This evidence concerns the gene CD8A and neoplasm.